These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 19825518)

  • 1. Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.
    Normand S; Massonnet B; Delwail A; Favot L; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):101-7. PubMed ID: 19825518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes.
    Massonnet B; Normand S; Moschitz R; Delwail A; Favot L; Garcia M; Bourmeyster N; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):112-20. PubMed ID: 19825520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1.
    Kuijk LM; Mandey SH; Schellens I; Waterham HR; Rijkers GT; Coffer PJ; Frenkel J
    Mol Immunol; 2008 Apr; 45(8):2158-65. PubMed ID: 18242710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-IgD syndrome or mevalonate kinase deficiency.
    Stoffels M; Simon A
    Curr Opin Rheumatol; 2011 Sep; 23(5):419-23. PubMed ID: 21760510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for geranylgeranylation in interleukin-1beta secretion.
    Mandey SH; Kuijk LM; Frenkel J; Waterham HR
    Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases.
    Savic S; Dickie LJ; Battellino M; McDermott MF
    Curr Opin Rheumatol; 2012 Jan; 24(1):103-12. PubMed ID: 22089100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
    Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
    Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-demand anakinra treatment is effective in mevalonate kinase deficiency.
    Bodar EJ; Kuijk LM; Drenth JP; van der Meer JW; Simon A; Frenkel J
    Ann Rheum Dis; 2011 Dec; 70(12):2155-8. PubMed ID: 21859689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.
    Kuijk LM; Beekman JM; Koster J; Waterham HR; Frenkel J; Coffer PJ
    Blood; 2008 Nov; 112(9):3563-73. PubMed ID: 18684863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome.
    Stoffels M; Jongekrijg J; Remijn T; Kok N; van der Meer JW; Simon A
    Rheumatology (Oxford); 2015 Feb; 54(2):363-8. PubMed ID: 25173351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
    Mandey SH; Schneiders MS; Koster J; Waterham HR
    Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hereditary autoinflammatory diseases.
    Ter Haar NM; Frenkel J
    Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
    Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of mevalonate kinase deficiency: comparison of cytokine and chemokine profile with that of human patients.
    Marcuzzi A; Zanin V; Kleiner G; Monasta L; Crovella S
    Pediatr Res; 2013 Sep; 74(3):266-71. PubMed ID: 23760140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
    Marcuzzi A; De Leo L; Decorti G; Crovella S; Tommasini A; Pontillo A
    Pediatr Res; 2011 Jul; 70(1):78-82. PubMed ID: 21430599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoinflammatory diseases.
    Touitou I; Koné-Paut I
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):811-29. PubMed ID: 19028365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances in the understanding and treatment of mevalonate kinase deficiency.
    Esposito S; Ascolese B; Senatore L; Bosis S; Verrecchia E; Cantarini L; Rigante D
    Int J Immunopathol Pharmacol; 2014; 27(4):491-8. PubMed ID: 25572728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
    Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
    Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.